Jamelor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Jamelor, covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis [Phase 3]